Business Context and Reporting Period
This Form 8-K was filed by Griffin-American Healthcare REIT IV, Inc. (American Healthcare REIT, Inc.) on September 18, 2017. The filing reports the entry into material definitive agreements regarding the acquisition of senior housing facilities in Florida and the authorization of new daily distributions to Class T and Class I stockholders.
Key Financial Metrics and Transaction Details
The filing details amendments to two purchase agreements for a portfolio of nine senior housing facilities in Central Florida:
- Spring Haven Portfolio (4 facilities): Contract purchase price reduced to $66,500,000 (from $70,000,000). An additional deposit of $875,000 is required.
- Bayside Portfolio (5 facilities): Contract purchase price reduced to $43,000,000 (from $47,500,000). An additional deposit of $1,125,000 is required.
- Total Portfolio Aggregate Price: $109,500,000 (reduced from $117,500,000), plus closing costs.
- Distribution Authorization: Daily distributions of $0.001643836 per share, equal to an annualized rate of $0.60 per share, for the period October 1, 2017, through December 31, 2017.
The filing text does not provide current revenue, profit, cash flow, margins, debt, or liquidity metrics for the company.
Material Changes and Contract Amendments
On September 18, 2017, the company executed first amendments to both the Spring Haven and Bayside Purchase Agreements. Key changes include:
- Price Reductions: Total purchase price reduced by $8,000,000 across both portfolios.
- Inspection Periods: Extended to September 22, 2017, for most properties, with a specific extension to September 30, 2017, for the Brooksville property.
- Regulatory Filings: The company agreed to file for Healthcare Approvals by September 18, 2017, and make required payments to the Florida Agency for Health Care Administration by September 19, 2017.
- Board Approval Deadline: The company must obtain board approval to consummate the transactions by September 29, 2017. Failure to do so grants the company the right to terminate the agreements by October 2, 2017, with a full return of deposits.
- Indemnity Structure: References to Indemnity Escrows were deleted. Recovery for claims will now be sought under the Guaranty instead.
Outlook, Risks, and Contingencies
The closing of the acquisitions is contingent upon several factors:
- Board Approval: Final approval is required by September 29, 2017.
- Regulatory Approvals: Obtaining necessary Healthcare Approvals from the State of Florida.
- Inspection Periods: Successful completion of inspections by the extended deadlines.
- Liquidity for Distributions: The authorized distributions for Q4 2017 will be paid only from legally available funds.
Investor Verification Checklist
- Confirm whether the Board of Directors approved the acquisitions by the September 29, 2017 deadline.
- Verify the receipt of Healthcare Approvals from the Florida Agency for Health Care Administration.
- Monitor the status of the additional deposits ($875,000 and $1,125,000) and their impact on cash flow.
- Review the final closing date and any further amendments to the purchase agreements.
- Assess the company's "legally available funds" to ensure the ability to pay the declared $0.60 annualized distribution.